745329
Last Update Posted: 2008-09-03
Recruiting status is unknown
Males accepted | 18 Years + |
100 Estimated Participants | No Expanded Access |
Observational Study | Accepts healthy volunteers |
The Effect of Infliximab on Sperm Quality
Background: The treatment of inflammatory bowel diseases (IBD) is based mainly on 3 compounds: 1- 5 aminosalysilates . 2- immunomodulators (Azathioprines). 3- Biologic therapies (Infliximab, Adalimumab) . There are no established data in the literature whether these therapies effects sperm quality. Given that a large number of the patients are young men in the reproductive stage of their lives , It of importance to investigate these effect.
Aim: To investigate the effect of chronic treatment of any of the three therapy mentioned above, on sperm quality .
Eligibility
Relevant conditions:
Crohn's Disease
Ulcerative Colitis
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov